NEWARK, Del. — September 12, 2026 — The global idiopathic short stature market is projected to grow from USD 2.9 billion in 2026 to USD 7.1 billion by 2036, expanding at a CAGR of 9.3% during the forecast period, according to a new market analysis by Future Market Insights (FMI). The market is gaining momentum as earlier endocrine assessment, established growth hormone treatment...